Co-delivery of azithromycin and nisin through liposomes for skin infection to reduce antimicrobial drug resistance.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Co-delivery of azithromycin and nisin through liposomes for skin infection to reduce antimicrobial drug resistance.
- Published In:
- International journal of pharmaceutics, 679, 125764 (2025)
- Authors:
- Gelen-Gungor, Dilek, Nigiz, Şeyma, Özkul, Ceren, Eroğlu, Hakan, Nemutlu, Emirhan, Ulubayram, Kezban, Mao, Yong, Michniak-Kohn, Bozena, Eroğlu, İpek
- Database ID:
- RPEP-11077
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-11077APA
Gelen-Gungor, Dilek; Nigiz, Şeyma; Özkul, Ceren; Eroğlu, Hakan; Nemutlu, Emirhan; Ulubayram, Kezban; Mao, Yong; Michniak-Kohn, Bozena; Eroğlu, İpek. (2025). Co-delivery of azithromycin and nisin through liposomes for skin infection to reduce antimicrobial drug resistance.. International journal of pharmaceutics, 679, 125764. https://doi.org/10.1016/j.ijpharm.2025.125764
MLA
Gelen-Gungor, Dilek, et al. "Co-delivery of azithromycin and nisin through liposomes for skin infection to reduce antimicrobial drug resistance.." International journal of pharmaceutics, 2025. https://doi.org/10.1016/j.ijpharm.2025.125764
RethinkPeptides
RethinkPeptides Research Database. "Co-delivery of azithromycin and nisin through liposomes for ..." RPEP-11077. Retrieved from https://rethinkpeptides.com/research/gelen-gungor-2025-codelivery-of-azithromycin-and
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.